Valuation: Virbac

Market Cap 277.72Cr 317.84Cr 255.03Cr 237.83Cr 450.87Cr 30TCr 458.48Cr 3.07TCr 1.19TCr 15TCr 1.19TCr 1.17TCr 51TCr P/E 2026 *
16.5x
P/E 2027 * 14.7x
Enterprise Value 289.82Cr 331.68Cr 266.14Cr 248.19Cr 470.51Cr 32TCr 478.45Cr 3.2TCr 1.24TCr 15TCr 1.25TCr 1.22TCr 53TCr EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.71x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.62%
1 day+0.45%
1 week-2.63%
Current month+0.15%
1 month-2.35%
3 months-4.17%
6 months-7.24%
Current year-6.85%
1 week 327.5
Extreme 327.5
347
1 month 327.5
Extreme 327.5
359
Current year 326.5
Extreme 326.5
389.5
1 year 296
Extreme 296
389.5
3 years 232.5
Extreme 232.5
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap.
22/24/22Sell

Chief Executive Officer

810 0.0096%
22/24/22Sell

Chief Executive Officer

140 0.0017%
22/24/22Sell

Chief Executive Officer

370 0.0044%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%-2.63%-3.62%+22.88% 317.84Cr
+3.24%-3.88%-52.98%-56.56% 3.14TCr
+3.78%+2.59%+69.84%+148.51% 1.25TCr
-1.18%-7.74%-14.64%+4.64% 378.14Cr
+1.36%-0.99%+50.06%+25.76% 192.4Cr
+1.66%0.00%-26.50%+17.77% 165.17Cr
+3.61%+4.49%+19.04%+142.77% 134.92Cr
+1.80%+3.31%-21.89%-13.99% 102.34Cr
+0.70%-0.41%-4.50%-21.63% 95Cr
+0.99%+1.50%-16.87%-47.69% 92Cr
Average +1.61%+0.82%-0.21%+22.25% 586.26Cr
Weighted average by Cap. +2.71%-1.65%-13.99%+6.20%

Financials

2026 *2027 *
Net sales 154.63Cr 176.97Cr 142Cr 132.42Cr 251.04Cr 17TCr 255.27Cr 1.71TCr 662.58Cr 8.26TCr 664.47Cr 650.03Cr 28TCr 163.95Cr 187.63Cr 150.55Cr 140.4Cr 266.16Cr 18TCr 270.66Cr 1.81TCr 702.5Cr 8.76TCr 704.51Cr 689.2Cr 30TCr
Net income 17Cr 19Cr 15Cr 14Cr 27Cr 1.82TCr 28Cr 184.66Cr 72Cr 892.54Cr 72Cr 70Cr 3.08TCr 19Cr 22Cr 17Cr 16Cr 31Cr 2.07TCr 31Cr 210.29Cr 81Cr 1.02TCr 82Cr 80Cr 3.5TCr
Net Debt 12Cr 14Cr 11Cr 10Cr 20Cr 1.32TCr 20Cr 133.77Cr 52Cr 646.57Cr 52Cr 51Cr 2.23TCr 2.65Cr 3.03Cr 2.43Cr 2.27Cr 4.3Cr 288.63Cr 4.37Cr 29Cr 11Cr 141.57Cr 11Cr 11Cr 487.82Cr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
03/26/03 330.50 -0.30% 505
02/26/02 €331.50 +0.45% 6,240
01/26/01 €330.00 -0.75% 5,366
30/26/30 €332.50 -1.92% 6,550
29/26/29 €339.00 -0.88% 3,278
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
331.50EUR
Average target price
412.88EUR
Spread / Average Target
+24.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock